Novel autoantibodies are implicated in hypertensive disorders of pregnancy, fetal growth restriction, and other pregnancy disorders

Fetal and neonatal therapies improve prognosis of congenital cytomegalovirus infection

Discovery of novel autoantibody that is a major risk factor for recurrent pregnancy loss

Issues with maternal screening for congenital cytomegalovirus infection